A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin (NCT07392190)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Persistent Obesity or Overweight Treated With a Weekly Incretin, With and Without Type 2 Diabetes
🩺 Plain-English Summary (8th-Grade Level)
The main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity or overweight, with or without type 2 diabetes, and on stable incretin background therapy. Participation in the study will last about 80 weeks.
Who can join: Review the eligibility criteria below.
Location: Birmingham Clinical Research — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (187 Sites)
Showing the first 25 of 187 sites.
- Birmingham Clinical Research — Birmingham, Alabama
- RIO Clinical Trials - Phoenix — Phoenix, Arizona
- Headlands Research - Scottsdale — Scottsdale, Arizona
- Novak Clinical Research - Tucson - North La Cholla Boulevard — Tucson, Arizona
- Irvine Clinical Research — Irvine, California
- Scripps Whittier Diabetes Institute — La Jolla, California
- EndoTrials Center for Clinical Research — La Mesa, California
- Peninsula Research Associates — Rolling Hills Estates, California
- Care Access - Sacramento — Sacramento, California
- Artemis Institute for Clinical Research — San Diego, California
- Southern California Clinical Research — Santa Ana, California
- University Clinical Investigators, Inc. — Tustin, California
- New England Research Associates, LLC — Bridgeport, Connecticut
- Yale University School of Medicine — New Haven, Connecticut
- Chase Medical Research, LLC — Waterbury, Connecticut
- JEM Research Institute — Atlantis, Florida
- AMR Clinical — Doral, Florida
- Northeast Research Institute (NERI) — Fleming Island, Florida
- Jacksonville Center for Clinical Research — Jacksonville, Florida
- New Horizon Research Center — Miami, Florida
- St Johns Center for Clinical Research — Saint Augustine, Florida
- Metabolic Research Institute, Inc. — West Palm Beach, Florida
- Teak Research Consults - Dunwoody — Dunwoody, Georgia
- Center for Advanced Research & Education — Gainesville, Georgia
- Clinical Research Atlanta — Stockbridge, Georgia
📞 Contact the Study Coordinator
Phone: (317) 615-4559
Email: LillyTrials@Lilly.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Overweight
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes — Northridge, California
- A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight — Tempe, Arizona
- A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity — Tempe, Arizona
- Partnerships for Reducing Overweight and Obesity with Patient-Centered Strategies 2.0 — Boston, Massachusetts
- Impact of Metabolic Health on Sperm Epigenetic Marks in Humans — Boston, Massachusetts
- The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults — Tallahassee, Florida
Explore by condition: All Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.